Campbell David Alan

CIK 00018641581 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001864158

Recent Transactions

20 trades

Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2026-07-08−7,000→ 697,550 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2026-07-08$4.21/sh+7,000→ 388,582 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2026-01-02$13.73/sh−8,072→ 284,982 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2026-01-02+96,600→ 381,582 total
Award
Janux Therapeutics, Inc.$JANX
Stock option (right to buy)
2026-01-02+338,100→ 338,100 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-07$60.00/sh−5,000→ 293,054 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02+81,000→ 298,054 total
Award
Janux Therapeutics, Inc.$JANX
Stock option (right to buy)
2025-01-02+283,500→ 283,500 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-12-24$56.19/sh−25,000→ 217,054 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-12-03$67.00/sh−15,000→ 242,054 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-11-25$51.43/sh−18,281→ 263,773 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-11-25$52.04/sh−6,719→ 257,054 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-28$53.22/sh−13,897→ 293,157 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-10-28$53.94/sh−11,103→ 282,054 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$47.84/sh−795→ 307,054 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$46.85/sh−5,248→ 307,849 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$46.09/sh−18,957→ 313,097 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-01-02+356,500→ 356,500 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2023-01-03+310,000→ 310,000 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2022-01-03+354,250→ 354,250 total

Companies

Janux Therapeutics, Inc.
Director, President and CEO
$JANX

Recent Filings

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130

View on SEC.gov